Literature DB >> 8056001

Left ventricular function in children with the Marfan syndrome.

A Savolainen1, L Nisula, P Keto, P Hekali, M Viitasalo, I Kaitila, M Kupari.   

Abstract

Aortic dilatation and heart valve lesions are common in the Marfan syndrome but whether primary alterations occur in left ventricular (LV) function has not been studied hitherto. LV size, mass and systolic as well as diastolic function were studied by M-mode and Doppler echocardiography and cine magnetic resonance imaging in 22 Marfan children aged 3.0-15.4 years and in 22 age-matched healthy children. No child had significant valve disease. Heart rate and systolic blood pressure were comparable in the groups but diastolic blood pressure was higher in the controls (67 +/- 7 mmHg vs 62 +/- 8 mmHg, P = 0.030). No statistically significant differences were found in LV size, mass or systolic function. The Marfan children had slower LV peak diameter lengthening rates (106 +/- 27 mm.s-1 vs 132 +/- 29 mm.s-1, P = 0.004), prolonged relaxation times (155 +/- 22 ms vs 140 +/- 19 ms, P = 0.023), slower deceleration of the early transmitral velocity (580 +/- 144 cm.s-1 vs 720 +/- 160 cm.s-2, P = 0.006), and smaller early-to-late peak velocity ratios (1.99 +/- 0.40 vs 2.29 +/- 0.46, P = 0.031). These data indicate that LV early diastolic function (relaxation) is impaired in the Marfan syndrome. Weakened elastic recoil due to the underlying connective tissue abnormality may best explain this novel observation.

Entities:  

Mesh:

Year:  1994        PMID: 8056001     DOI: 10.1093/oxfordjournals.eurheartj.a060558

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

Review 1.  Initial description of radiofrequency catheter ablation as treatment for atrial flutter in Marfan's syndrome: a case report and literature review.

Authors:  Ahmad Halawa; Vipul Brahmbhatt; Stephen A Fahrig
Journal:  J Interv Card Electrophysiol       Date:  2007-06-28       Impact factor: 1.900

2.  Midterm results after aortic valve-sparing operation.

Authors:  M Ninomiya; S Takamoto; Y Kotsuka; T Miyairi; T Morota; H Kubota
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

3.  Left atrial strain in the assessment of diastolic function: providing new insights into primary myocardial dysfunction in Marfan syndrome.

Authors:  Eusebio García-Izquierdo; Vanessa Moñivas-Palomero; Alberto Forteza; Carlos Martín-López; Mario Torres-Sanabria; Xabier Cia-Mendioroz; Consuelo Olivo-Rodríguez; Sara Navarro-Rico; Andrés Sánchez-Gómez; Jesús G Mirelis; Miguel A Cavero; Susana Mingo-Santos
Journal:  Int J Cardiovasc Imaging       Date:  2021-04-19       Impact factor: 2.357

Review 4.  Marfan syndrome. Part 1: pathophysiology and diagnosis.

Authors:  Victoria Cañadas; Isidre Vilacosta; Isidoro Bruna; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2010-03-30       Impact factor: 32.419

5.  Evaluation of cardiac functions of patients with benign joint hypermobility syndrome.

Authors:  Sevket Balli; Mehmet Zafer Aydın; Vedat Gerdan; Ibrahim Ece; Mehmet Burhan Oflaz; Ayse Esin Kibar; Eylem Sen Dalkiran
Journal:  Pediatr Cardiol       Date:  2013-09-08       Impact factor: 1.655

Review 6.  Marfan's syndrome and the heart.

Authors:  Alan Graham Stuart; Andrew Williams
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

7.  Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome.

Authors:  B B Das; A L Taylor; A T Yetman
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

8.  Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes.

Authors:  Hyun-Jin Tae; Natalia Petrashevskaya; Shannon Marshall; Melissa Krawczyk; Mark Talan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-13       Impact factor: 4.733

9.  Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome.

Authors:  Jason R Cook; Luca Carta; Ludovic Bénard; Elie R Chemaly; Emily Chiu; Satish K Rao; Thomas G Hampton; Peter Yurchenco; Kevin D Costa; Roger J Hajjar; Francesco Ramirez
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

Review 10.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.